IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Strides Agrees on Injectables Deal

8:53 AM MST | November 7, 2007 | Chemical Week Editorial Staff

Pharmaceutical company Strides Arcolab (Bangalore, India) says it has agreed on a deal with pharma manufacturer Sagent Pharmaceuticals (Schaumburg, IL) to jointly develop, supply, and market injectable products for the U.S. market. Strides Arcolab will develop and supply injectable products that Sagent will market in the U.S., under terms of the deal. The agreement will initially target 25 products, the companies say. Sagent is a privately held specialty pharma company that was founded in 2006. “The strength and experience of our sales organization as well...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa